Employer profile
Astellas Gene Therapies
1 certified H-1B filings across 1 fiscal year.
FY2025 filings
1
FY2025 median
$144k
Top role
Scientist Ii, Bioanalytics
1 filings
Top state
CA
1 filings
Astellas Gene Therapies has filed 1 certified H-1B Labor Condition Applications over FY2025. In FY2025, its median certified base salary was $144k ($144k–$144k interquartile range). The most-filed role is Scientist Ii, Bioanalytics (1 filings).
Year-over-year
How Astellas Gene Therapies hired across H-1B fiscal years. YoY column compares to the prior FY.
| FY | Filings | Median $ | YoY % |
|---|---|---|---|
| FY2025 | 1 | $144k | — |
Top job titles
Most-filed positions, across all years (raw DOL titles).
| Job Title | Filings | Median |
|---|---|---|
| Scientist Ii, Bioanalytics | 1 | $144k |
Top worksite states
Where this employer files.
| State | Filings | Median |
|---|---|---|
| CA | 1 | $144k |
Prevailing wage level distribution
DOL Levels I–IV approximate experience tiers (I = entry, IV = fully competent). A heavy Level I/II skew suggests entry-level / contractor-style hiring; a heavy IV skew suggests senior in-house roles.
Lvl II
1100%
Frequently asked questions
- Does Astellas Gene Therapies sponsor H-1B visas?
- Yes. Astellas Gene Therapies has filed 1 certified H-1B Labor Condition Applications (LCAs) over FY2025. An LCA is a required step before an employer files an H-1B petition; a certified LCA does not by itself guarantee an approved visa.
- What is the median H-1B salary at Astellas Gene Therapies?
- In FY2025, the median certified H-1B base salary at Astellas Gene Therapies was $144k, with a 25th–75th percentile range of $144k–$144k. This is the annual base wage stated on the LCA and excludes bonus, equity, and other compensation.
- What jobs does Astellas Gene Therapies hire H-1B workers for?
- Astellas Gene Therapies's most-filed H-1B role is Scientist Ii, Bioanalytics (1 filings). Its top worksite state is CA.
- How many H-1B filings did Astellas Gene Therapies submit in FY2025?
- Astellas Gene Therapies had 1 certified H-1B LCA filings in FY2025.